Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: J Clin Psychiatry. 2016 Feb;77(2):212–220. doi: 10.4088/JCP.14m09505

Table 3.

Hazard Analysis for 11-year Follow-up

Unadjusted Multivariable-adjusteda

Hazards Ratio 95% CI p-value Hazards Ratio 95% CI p-value
LDL Cholesterol

175+ mg/dL reference reference
153-174 mg/dL 1.10 0.93-1.30 0.27 1.20 1.00-1.43 0.055
134-152 mg/dL 1.06 0.90-1.25 0.50 1.16 0.97-1.39 0.11
114-133 mg/dL 1.06 0.90-1.25 0.49 1.09 0.90-1.30 0.40
<114 mg/dL 1.25 1.07-1.47 0.0055 1.25 1.05-1.49 0.014

HDL Cholesterol

66+ mg/dL reference reference
56 – 66 mg/dL 1.04 0.89-1.21 0.63 1.00 0.85-1.18 0.99
50 - 56 mg/dL 1.04 0.89-1.22 0.61 0.92 0.78-1.10 0.38
43 – 50 mg/dL 1.00 0.85-1.16 0.95 0.82 0.69-0.98 0.03
< 43 mg/dL 1.09 0.92-1.28 0.31 0.81 0.67-0.98 0.029

Total Cholesterol

260+ mg/dL reference reference
236 – 259 mg/dL 0.99 0.84-1.18 0.94 1.09 0.91-1.31 0.33
216 – 235 mg/dL 1.10 0.94-1.30 0.23 1.17 0.98-1.40 0.08
195 - 215 mg/dL 1.05 0.89-1.24 0.58 1.07 0.89-1.28 0.48
< 195 mg/dL 1.15 0.98-1.36 0.08 1.11 0.93-1.33 0.23

Triglycerides

185+ mg/dL reference reference
136 – 184 mg/dL 0.93 0.80-1.09 0.39 0.957 0.81-1.13 0.61
106 – 135 mg/dL 0.91 0.78-1.07 0.25 1.004 0.85-1.19 0.97
80 – 105 mg/dL 0.92 0.78-1.07 0.28 1.041 0.87-1.24 0.65
< 80 mg/dL 0.80 0.68-0.95 0.0089 0.962 0.79-1.17 0.69
a

Adjusted for WHI trial arm, BMI, lipid-lowering medication, blood pressure, smoking status, coronary heart disease, stroke, peripheral artery disease, age, U.S. region, ethnicity, marital status, health insurance, alcohol consumption, leisure-time physical activity, cancer, income, education, diabetes, thyroid disease, and colitis